Onkure Therapeutics Inc stock is traded at $2.53, with a volume of 325,167. It is down -2.51% in the last 24 hours and up +2.64% over the past month. OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
Previous Close:
$2.59
Open:
$2.54
24h Volume:
325,167
Relative Volume:
0.87
Market Cap:
$104.00M
Revenue:
-
Net Income/Loss:
-$58.75M
P/E Ratio:
-
EPS:
-$4.33
Net Cash Flow:
-$50.79M
1W Performance:
-3.63%
1M Performance:
+2.64%
6M Performance:
-37.96%
1Y Performance:
-20.09%
1-Day Range:
$0.00$0.00
1-Week Range:
$2.32$2.72
52-Week Range:
$2.01$5.38
Onkure Therapeutics Inc Stock (OKUR) Company Profile
Name
Onkure Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
(720) 307-2892Address
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS